Welcome to LookChem.com Sign In|Join Free

CAS

  • or

870487-04-0

Post Buying Request

870487-04-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

870487-04-0 Usage

General Description

The chemical "(S)-(9H-fluoren-9-yl)methyl (1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)carbamate" is a complex compound consisting of a fluorenyl methyl group, a ureido pentan-2-yl carbamate group, and a hydroxymethyl phenylamino group. It belongs to the carbamate class of compounds and is characterized by its potential biological and pharmacological activities. The compound may have applications in various fields such as pharmaceuticals, agrochemicals, and material sciences, but further research and testing are needed to determine its specific properties and uses.

Check Digit Verification of cas no

The CAS Registry Mumber 870487-04-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,0,4,8 and 7 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 870487-04:
(8*8)+(7*7)+(6*0)+(5*4)+(4*8)+(3*7)+(2*0)+(1*4)=190
190 % 10 = 0
So 870487-04-0 is a valid CAS Registry Number.

870487-04-0Relevant articles and documents

A Wireframe DNA Cube: Antibody Conjugate for Targeted Delivery of Multiple Copies of Monomethyl Auristatin E

Gothelf, Kurt V.,M?rcher, Anders,Nijenhuis, Minke A. D.

supporting information, p. 21691 - 21696 (2021/09/02)

In recent years, several antibody drug conjugates (ADC) have been accepted by the FDA as therapeutics against cancer. It is well-known that control of drug-to-antibody ratio (DAR) is vital for the success of an ADC, which inspires the advancement of bette

NEW TARGETED CYTOTOXIC RATJADONE DERIVATIVES AND CONJUGATES THEREOF

-

Paragraph 00171; 00172, (2019/02/25)

The present invention is directed to novel natural product-derived ratjadone-based compounds useful as payloads (or toxins) in drug-conjugates constructs with cell target binding moieties (CTBM) and payload-linker compounds useful in connection with drug conjugates. The present invention further relates to new ratjadone compositions including the aforementioned payloads, payload-linkers and drug conjugates, and methods for using these payloads, payload-linkers and drug conjugates, to treat pathological conditions including cancer, inflammatory and infectious diseases.

BIOCOMPATIBLE AND HYDROPHILIC POLYMER CONJUGATE FOR TARGETED DELIVERY OF AN AGENT

-

Paragraph 0487, (2019/11/04)

The present invention provides a biocompatible and hydrophilic polymer conjugate comprising a linear, aliphatic copolymer backbone to which is conjugated a binding moiety and an agent. The binding moiety is conjugated to an end of the copolymer backbone a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 870487-04-0